Patient Pathfinder: Clinical Trials
Clinical Trials for Non Hodgkin Lymphoma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 515 active Non Hodgkin Lymphoma trials
Haplo Peripheral Blood Sct In GVHD Prevention
Study Type: Interventional Phase 1
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Study Type: Interventional Phase 1
Family Study of Lymphoproliferative Disorders
Study Type: Observational
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
Study Type: Interventional Phase 2
Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Study Type: Interventional Phase 2
Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
Study Type: Interventional Phase 2
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Study Type: Interventional Phase 2
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide
Study Type: Interventional Phase 2
There are 515 active Non Hodgkin Lymphoma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now